Getagraph.com logo
S&P 500
(1.02%) 5 099.96 points
Dow Jones
(0.40%) 38 240 points
Nasdaq
(2.03%) 15 928 points
Oil
(-0.47%) $83.46
Gas
(-1.16%) $1.619
Gold
(-0.05%) $2 346.00
Silver
(-0.27%) $27.46
Platinum
(0.21%) $924.00
USD/EUR
(0.29%) $0.934
USD/NOK
(0.62%) $11.02
USD/GBP
(0.08%) $0.800
USD/RUB
(0.00%) $92.17

Realaus laiko atnaujinimai RPG Life Sciences Limited [RPGLIFE.NS]

Birža: NSE Sektorius: Healthcare Pramonė: Drug Manufacturers—Specialty & Generic
Upcoming Earnings Alert

2 days till quarter result
(bmo 2024-04-30)

Expected move: +/- 4.25%

Atnaujinta26 bal. 2024 @ 13:00
25% discount on Stockinvest.us - Use code: Podcast

1.20% INR 1 567.30

Live Chart Being Loaded With Signals

Commentary (26 bal. 2024 @ 13:00):

RPG Life Sciences Limited, an integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally...

Stats
Šios dienos apimtis 22 781.00
Vidutinė apimtis 20 592.00
Rinkos kapitalizacija 25.92B
EPS INR0 ( 2024-04-26 )
Kita pelno data ( INR0 ) 2024-04-30
Last Dividend INR12.00 ( 2023-07-21 )
Next Dividend INR0 ( N/A )
P/E 30.58
ATR14 INR1.337 (0.09%)

Tūris Koreliacija

Ilgas: -0.14 (neutral)
Trumpas: -1.00 (very strong negative)
Signal:(39.518) Neutral

RPG Life Sciences Limited Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

RPG Life Sciences Limited Koreliacija - Valiuta/Žaliavos

The country flag -0.02
( neutral )
The country flag -0.51
( weak negative )
The country flag 0.11
( neutral )
The country flag -0.04
( neutral )
The country flag 0.43
( neutral )
The country flag -0.42
( neutral )

RPG Life Sciences Limited Finansinės ataskaitos

Annual 2022
Pajamos: INR5.13B
Bruto pelnas: INR3.42B (66.68 %)
EPS: INR40.90
FY 2022
Pajamos: INR5.13B
Bruto pelnas: INR3.42B (66.68 %)
EPS: INR40.90
FY 2022
Pajamos: INR4.37B
Bruto pelnas: INR2.87B (65.64 %)
EPS: INR31.13
FY 2021
Pajamos: INR3.83B
Bruto pelnas: INR2.46B (64.10 %)
EPS: INR24.19

Financial Reports:

No articles found.

RPG Life Sciences Limited Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
INR9.60
(N/A) 		INR0
(N/A) 		INR0
(N/A) 		INR0
(N/A) 		INR12.00
(N/A) 		INR0
(N/A) 		INR0
(N/A) 		INR0
(N/A) 		INR0
(N/A) 		INR0
(N/A)

RPG Life Sciences Limited Dividend Information - Dividend Junior

Dividend Sustainability Score: 3.08 - low (2.49%) | Divividend Growth Potential Score: 4.87 - Stable (2.53%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend INR1.200 2008-08-11
Last Dividend INR12.00 2023-07-21
Next Dividend INR0 N/A
Payout Date 0000-00-00
Next Payout Date N/A
# dividends 16 --
Total Paid Out INR51.04 --
Avg. Dividend % Per Year 1.03% --
Score 2.26 --
Div. Sustainability Score 3.08
Div.Growth Potential Score 4.87
Div. Directional Score 3.97 --
Next Divdend (Est)
 (2024-06-27)
INR13.68 Estimate 3.11 %
Dividend Stability
0.25 Very Poor
Dividend Score
2.26
Pay Frequency
Annually
Yearly Payout
Year Amount Yield
2008 INR0 0.00%
2009 INR0 0.00%
2010 INR0 0.00%
2011 INR0 0.00%
2012 INR0 0.00%
2013 INR0 0.00%
2014 INR0 0.00%
2015 INR0 0.00%
2016 INR0 0.00%
2017 INR0 0.00%
2018 INR2.40 0.61%
2019 INR2.40 1.01%
2020 INR4.00 1.26%
2021 INR7.20 1.92%
2022 INR9.60 1.57%
2023 INR12.00 1.41%
2024 INR0 0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NSE

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
KRBL.NS Dividend Junior 2023-08-25 Annually 23 0.61%
FCL.NS Dividend Junior 2023-09-08 Annually 10 0.22%
ANANTRAJ.NS Dividend Junior 2023-06-27 Annually 18 0.22%
TATACOFFEE.NS Dividend Junior 2023-05-15 Annually 23 0.85%
NIACL.NS No Dividend Player 2023-09-07 Sporadic 7 0.44%
INDIAGLYCO.NS Dividend Junior 2023-09-05 Sporadic 20 0.85%
CHOLAHLDNG.NS Dividend Junior 2023-08-03 Annually 23 0.06%
SANDHAR.NS Dividend Junior 2023-09-14 Annually 7 0.66%
LXCHEM.NS Dividend Junior 2023-07-20 Annually 4 0.11%
GLENMARK.NS Dividend Junior 2023-09-18 Annually 23 0.37%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.1481.5007.0410.00[0 - 0.5]
returnOnAssetsTTM01.20000[0 - 0.3]
returnOnEquityTTM0.2641.5008.1810.00[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM00.800-5.00-4.00[1 - 3]
quickRatioTTM00.800-4.71-3.76[0.8 - 2.5]
cashRatioTTM01.500-1.111-1.667[0.2 - 2]
debtRatioTTM0-1.50000[0 - 0.6]
interestCoverageTTM309.811.00010.0010.00[3 - 30]
operatingCashFlowPerShareTTM19.922.003.366.72[0 - 30]
freeCashFlowPerShareTTM19.922.000.04180.0835[0 - 20]
debtEquityRatioTTM0-1.50000[0 - 2.5]
grossProfitMarginTTM0.6171.0003.053.05[0.2 - 0.8]
operatingProfitMarginTTM0.1941.0008.118.11[0.1 - 0.6]
cashFlowToDebtRatioTTM01.000-1.111-1.111[0.2 - 2]
assetTurnoverTTM00.800-3.33-2.67[0.5 - 2]
Total Score3.08

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM30.581.0007.010[1 - 100]
returnOnEquityTTM0.2642.508.8310.00[0.1 - 1.5]
freeCashFlowPerShareTTM19.922.003.360.0835[0 - 30]
dividendYielPercentageTTM0.7661.50010.000[0 - 0.4]
operatingCashFlowPerShareTTM19.922.003.366.72[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM1.0661.5006.230[0.5 - 2]
operatingCashFlowSalesRatioTTM0.05741.000-1.0640[0.1 - 0.5]
Total Score4.87

RPG Life Sciences Limited

RPG Life Sciences Limited, an integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally. The company offers synthetic APIs in various therapeutic categories, including immunosuppressants, anti-psychotic, anti-anginal, anthelmentics, anti-convulsant, anti-spasmodic, etc. It also provides generics primarily in area of immunosuppressant therapy; and finished dosage formulations for various therapies, such as nephrology, rheumatology, oncology, gastroenterology, cardiovascular, diabetology, orthopedics, neuropsychiatry, respiratory, nutritional, general, urology, anti-diabetic, anti-dengue, vitamins and minerals, gynecology and pediatrics, etc. The company was formerly known as RPG Pharmaceuticals Limited and changed its name to RPG Life Sciences Limited in February 2008. RPG Life Sciences Limited was founded in 1968 and is headquartered in Mumbai, India. RPG Life Sciences Limited is a subsidiary of Nucleus Life Trust.

Apie Signalai gyvai

Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.

Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.